Flanders (BE2)

Flanders has showcased as a region with great potential in the pharmaceutical market. The region is characterised by exceptionally rapid approval times for clinical trials and puts heavy emphasis on biotech R&D, through a well-developed ecosystem of startups, SMEs and larger international companies. Different strategic research centra (VIB, imec, VITO) focus on aspects related to personalised medicine and work on the valorisation of their research.

 

Personalised medicine is furthermore one of the priorities in Flanders' smart specialisation strategy. In this light, Flanders is one of the leading regions in the smart specialisation partnership on personalised medicine (S3P4PM) and coordinator of the SAPHIRe project.

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

Major initiatives

  1. GAP (Genomics Application Platform)  https://www.imec-int.com/en/what-we-offer/research-portfolio/gap

  2. S3P4PM  https://s3platform.jrc.ec.europa.eu/personalised-medicine

  3. emma.health  https://emma.health/

  4. VIB Grand Challenges program  http://www.vib.be/nl/over-vib/grandchallenges/Paginas/default.aspx

  5. HELIUM https://www.interregeurope.eu/helium/

  6. Elixir Belgium Data  https://www.elixir-belgium.org/index.php/node/179

  7. # Centers for Medical Genetics  Genome sequencing infrastructure  https://www.demaakbaremens.org/themas/genetica/adressen-centra-voor-medische-genetica/

  8. VIB  strategic research centra  http://www.vib.be/en/Pages/default.aspx

  9. imec  strategic research centra https://www.imec-int.com/en/home

  10. VITO  strategic research centra  https://vito.be/en

 

 

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?

  1. S3P4PM - (https://s3platform.jrc.ec.europa.eu/personalised-medicine)

  2. https://www.eithealth.eu/belgium-the-netherlands

SHAPIRE SOCIAL ICONS-3.jpg
SHAPIRE SOCIAL ICONS-2.jpg
SHAPIRE SOCIAL ICONS-4.jpg

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium